$416.99After hours+23.94% · 3M
Moving avg
1W+2.80%
1M+17.15%
3M+23.78%
6M+13.65%
YTD+27.02%
1Y+43.84%
3Y+59.47%
5Y+81.20%
52-week range
$269.77100% of range$391.29
Company health
Value1/6
Growth2/6
Profitability6/6
Health2/6
Dividend3/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Strong 21% net margin
- High return on equity (8941%)
- Pays a 2.6% dividend
Risks
- Trades 15% above the average analyst target
- Highly leveraged (debt is 6.3x equity)
Key statistics
Valuation
Market cap
$224.62B
Enterprise value
$248.24B
P/E ratio (TTM)
25.97x
P/S ratio (TTM)
5.45x
EV/EBITDA
14.88x
Per share & returns
EPS (TTM)
$14.44
Dividend yield
2.61%
Beta (1Y)
0.40
30-day change
+17.15%
Trading
Volume (24h)
0
Previous close
$414.30
Shares outstanding
539.71M
About Amgen Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Symbol
AMGN
Amgen Inc. is a mega-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NASDAQ (United States) and trade under the ticker AMGN.
Frequently asked questions
What is Amgen Inc.'s market cap?
Amgen Inc. (AMGN) has a market capitalization of $224.62B.
What is Amgen Inc.'s P/E ratio?
Amgen Inc. trades at a price-to-earnings (P/E) ratio of 25.97.
What exchange does AMGN trade on?
AMGN trades on NASDAQ.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$358.08B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.55B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.81B cap